Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Double Cord Versus Haploidentical (BMT CTN 1101)

NCT01597778

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +30 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Cancer Center Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
View all 39 locations
View Trial Details
Completed

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

NCT01777152

Conditions
Anaplastic Large-Cell Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Shands Cancer Center / University of Florida Gainesville, Florida, United States
View all 144 locations
View Trial Details
Completed

Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia.

NCT01641107

Conditions
Acute Lymphoblastic Leukemia, BCR-ABL Positive, Hematologic Diseases, +11 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli Piceno, Italy
  • Az.Ospedaliera S.G.Moscati Avellino, Italy
View all 42 locations
View Trial Details
Completed

Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

NCT02120157

Conditions
Bone Marrow Diseases, Graft Survival, HLA-mismatched Bone Marrow Transplantation, +17 more
Locations
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Nemours Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States
  • All Children's Hospital Johns Hopkins Medicine St. Petersburg, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

NCT01321541

Conditions
DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Disease Attributes, +17 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Highlands Oncology Group Bentonville, Arkansas, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
View all 131 locations
View Trial Details

Related conditions